Cefotaxime in the treatment of gonorrhoea caused by beta-lactamase-producing Neisseria gonorrhoeae.
Of 118 patients infected with beta-lactamase producing Neisseria gonorrhoeae treated with cefotaxime 0.5 g, 95 returned for at least one assessment. There were no failures to eradicate genital or rectal infection, but three of four patients with pharyngeal infection failed to respond.
D002439:Cefotaxime / Q000627:therapeutic use*; D006069:Gonorrhea / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D009344:Neisseria gonorrhoeae / Q000201:enzymology; D001618:beta-Lactamases / Q000096:biosynthesis*
D001618:beta-Lactamases; D002439:Cefotaxime